**To the Editor:** We thank Dr. Meshikhes for his comments regarding our article, but we are not in agreement with his criticisms. To the best of our knowledge, our study was the first of the triple test in Saudi females, in a prospective trial, in 140 patients and using confirmatory open biopsy in all patients. Contrary to Dr. Meshikhes statement, we showed the mean age and age range of the patients (mean age, 44years; range, 35 to 65 years) in the results (page 159). All patients in the study were 35 years or older.

In response to his comments on mammography, we mentioned the increasing use of ultrasonography and the possibility that it might replace mammography in the future. We do not accept his interpretation of resources and cost use. Many breast cancer cases in Saudi Arabia occur in women younger than 40 years and most are advanced. Not recognizing this fact is very dangerous. We advise proper use of the triple component. We are not recommending liberal use of the mammogram or mass screening, or the use of the mammogram in cases of fibroadenomas. The aim of our research is to improve the quality of medical service locally by eliminating improper practices.
